CBLL — Ceribell, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1861107 ·
Last close
$17.69
Market Cap
$671.21M
52W High
$20.93
52W Low
$15.84
ADV30
395,607
Next earnings
2026-08-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,494,000 | 23,122,000 | -20,745,000 | -19,737,000 | 178,078,000 | 45,252,000 | 37,265,000 |
| Dec 2025 | 24,784,000 | 21,643,000 | -14,596,000 | -13,527,000 | 195,803,000 | 40,476,000 | 40,467,000 |
| Sep 2025 | 22,589,000 | 19,942,000 | -14,647,000 | -13,465,000 | 199,525,000 | 23,739,000 | 35,444,000 |
| Jun 2025 | 21,199,000 | 18,682,000 | -14,952,000 | -13,643,000 | 207,689,000 | 40,141,000 | 35,534,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-48,702,000
Investing CF
$-66,087,000
Financing CF
$6,681,000
CapEx
$-1,653,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.63
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-220,356,000
Inventory
$7,288,000
Receivables
$15,053,000
ST Investments
$118,785,000
EBIT TTM
$-51,522,000
Pretax Income TTM
$-53,412,000
Interest Exp TTM
$1,890,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$95,066,000
EBITDA
$-63,695,000
Free Cash Flow
$-29,333,624
Enterprise Value
$552,138,368
Total Cash
$141,184,000
Total Debt
$22,116,000
Shares Out
37,942,700
Trailing EPS
$-1.62
Book Value
$3.72
ROE
-37.5%
ROA
-20.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 89,063,000 | -58,402,000 | -53,412,000 | 195,803,000 | 40,467,000 | — | -40,808,000 |
| Dec 2024 | 65,444,000 | -39,709,000 | -40,455,000 | 225,412,000 | 34,247,000 | — | -35,043,000 |
| Dec 2023 | 45,225,000 | -30,041,000 | -29,464,000 | 58,922,000 | 171,174,000 | — | -29,159,000 |
| Dec 2022 | 25,922,000 | -36,021,000 | -37,164,000 | 86,458,000 | 172,856,000 | — | -32,002,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.10
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $17.69 · call volume: 100 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $635.41M | $28.17 | — |
| ANGO | ANGIODYNAMICS INC | $611.31M | $14.79 | — |
| BWAY | Brainsway Ltd. | $611.20M | $15.23 | — |
| BRSYF | Brainsway Ltd. | $607.19M | $15.13 | — |
| MDXG | MIMEDX GROUP, INC. | $601.99M | $4.13 | — |
News headlines (Yahoo Finance, 1h cache)
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
2026-07-29 11:00 · Yahoo
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-28 20:05 · Yahoo
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
2026-07-20 20:05 · Yahoo
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
2026-06-27 15:31 · Yahoo
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
2026-06-08 11:00 · Yahoo
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
2026-05-20 20:05 · Yahoo
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records
2026-05-15 05:07 · Yahoo
CeriBell, Inc. Q1 2026 Earnings Call Summary
2026-05-12 12:30 · Yahoo
CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ...
2026-05-12 07:07 · Yahoo
CeriBell Q1 Earnings Call Highlights
2026-05-11 23:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.